Synlett 1997; 1997(5): 589-590
DOI: 10.1055/s-1997-3225
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

A Concise Stereoselective Synthesis of Epibatidine Employing Conjugate Addition to an Alkenyl Sulfone Intermediate as the Key Step

Gerrard M. P. Giblin1 , Clifford D. Jones2 , Nigel S. Simpkins3
  • 1Glaxo Wellcome, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, England, U.K.
  • 2Department of Chemistry, The University of Nottingham, University Park, Nottingham, NG7 2RD, UK
  • 3Department of Chemistry, The University of Nottingham, University Park, Nottingham, NG7 2RD, UK, Fax (0115) 9513564; e-mail nigel.Simpkins@Nottingham.ac.uk
Further Information

Publication History

Publication Date:
31 December 2000 (online)

A new synthesis of racemic epibatidine has been achieved, which involves conjugate addition of a metallated 2-methoxypyridine derivative to a suitably protected azabicyclic alkenyl sulfone as the key step.